42 patients received cyclosporine. Our current one-year graft survival in all recipients of LRD allografts is 95%, cyc1osporine being used in all except HLA-identical recipients.
Twenty-one patients (50%) currently have functioning allografts 1-14 ye posttransplantation (mean: 5 years). Allograft failure occurred eight patients within one year following transplantation. In 0 of these patients, arterial occlusion resulted in graft loss a 1 and 3 days, respectively. In the remaining six patients, rej . n was responsible for graft loss. In three of these six patients, im osuppreasion was less than optimum because of concurrent se . A fourth patient was noncompliant with her immunosup ssive medications. Chronic rejection led to graft loss at 20 mo s in one patient and at 6, 7, and 14 years posttransplantation . respectively.
In summary, no adverse affect upon patient s . al was noted due to the presence of MRA. MRA, however, adv Iy affected graft survival in two cases. One allograft was lost the early postoperative period due to infarction following rep . of a completely transected superior polar vessel. It mus stressed that this complication has not occurred sin 976, and therefore, as more experience was gained, inju to these small vessels has been avoided. In the second pa . nt, ligation of a superior polar vessel with resultant hype sion may have contributed to allograft loss 20 months fo wing transplantation.
The presence of MRA and the a tional time required for arterial reconstruction contribu to postoperative ATN in only one patient, who required enous patch angioplasty prior to arterial reconstruction. I our recent experience, renovascular hypertension seeon to RAS occurred in 39 of 547 renal allograft recipien 7.1 %) (2) . In the present series, RAS was present in 5% patients. In all cases RAS occurred proximal to the . al reconstruction. The most freque urologic complication in the present series was distal ureteral fistula (in three patients). Interference with blood flow to the ureter may have occurred during dissection of the inferior polar artery. The presence of multiple renal arteries has previously been recognized as contributing to the formation of ureteral fistulae (3). Concurrent rejection in one patient may also have further affected blood flow to the ureter.
No allografts were lost secondary to urologic complications.
In conclusion, the present study demons tes that the use of donors with MRA is associated wit creased risk to the allograft. Nonetheless, satisfactol'Y. tient and graft survival was achieved. Exclusion of don based upon the presence of MRA would deny a large n r of patients the advantages of an LRD renal allo in our series, and place further supply of cadaveric renal allografts. 
PORTAL VEIN THROMBOEMBOLISM OF LIVER ALWGRAFrS FROM SPLENECTOMIZED DONORS!
Since first reported by Delatour (1) in 1895, thrombosis of the splenoportal venous system has been known as a serious complication of splenectomy. This complication primarily affects patients with congestive splenomegaly and myeloproliferative disorders (2, 3), and is supposedly rare after splenectomy for trauma or incidental injury during laparotomy (4, 5). We describe two patienta who underwent splenectomy for trauma, in whom thromboembolism of the portal vein was identifIed later in the livers harvested for liver transplantation. Case 1. A 13-year-old boy was involved in a traffic accident on July 1, 1987, and suffered from multiple trauma. The patient underwent splenectomy, in addition to other procedures. Because of irreversible head injury, the patient became a multiple organ donor, and the heart, Over and left kidney, were procured. The laboratory data before the organ donation were: SGOT 100 lUlL, SGPT 46 lUlL, total bilirubin 1.7 mg/dl, prothrombin time 13.7 sec, partial thromboplastin time 24.S sec, leuko- cyte count 12.5X1~/mm3, hematocrit level 42.4%. The platelet count was not measured. At the time of organ procurement, the liver appeared grossly normal and soft on palpation, and the intestine showed no evidence of venous congestion or edema. A small amount of serosanguinous fluid was seen in the peritoneal cavity. In view of the extensive retroperitoneal hematoma. a rapid flush technique (6) was used: Briefly, the portal cannula was inserted into the portal vein through the inferior mesenteric vein; following croea-clamp of the supraceliac aorta, the intraabdominal organs were flushed with cold solution from the portal as weD as terminal aortic cannulae. The allograft hepatectomy was uneventful with immediate blanching and fast cooling of the liver. The liver was then transplanted into a recipient with Laennec'. cirrhoeia. When the donor portal vein was transected prior to ita anastomosis with the recipient portal vein, a fresh clot was found at the cut margin. The clot, which was cylindrical and measured 6.2X0.4xO.2 cm, was removed and a Fogarty catheter was passed into the allograft portal vein, which showed DO evidence of residual thromboemboli.
Following the portal vein anastomosis, the liver allograft was revascularized, and excellent reperfusion was observed. The clot was removed and the portal vein anastomosis was completed. The allograft perfused and functioned well. A Doppler ultrasonograph performed on the eighth postoperative day showed patent portal vein without any evidence of portal vein thromboemboli. The recipient was discharged 28 days postoperatively with good graft function. Both donors were victims of multiple trauma in traffic accidenta, for whom splenectomy was performed for blunt abdominal trauma. At the time of multiple organ donation, the liver and intestines showed no evidence of pathology, and liver allografts were harvested without technical difficulty. The intervale between splenectomy and multiple organ donation was 1 and 4 days, respectively. Fresh or semi-organized clota were identified lying loose in the portal vein of the liver allografts immediately before the portal vein anastomosis in the recipienta.
It is unlikely that the donors had portal or superior mesenteric vein thrombosis before multiple organ donation, since the liver and intestines looked grossly normal, no bloody ascites or melena was observed, and posttransplant liver functions in the recipienta of the livers were excellent without ischemic damage. Also, formation of a thrombus in the portal or superior mesenteric vein during liver harvesting in case 1 is unlikely, since the portal cannula was inserted immediately before crossclamping of the aorta, without interfering with the superior mesenteric venous flow, and since 3 mi/kg of heparin was administered immediately after the portal cannulation.
Salter et al. (4) reported splenic vein thrombosis after splenectomy in 3 out of 7 patienta (42.9%) on autopsy, and Broe et al. (3) described 2 patienta in whom postmortem examination ~ the extension of thrombus from the splenic vein remnant to the portal vein. Since the splenic vein after the splenectomy becomes a cul-de-sac with very low flow, it is not surprising for a thrombus to form in this remnant structure (3) . Allograft hepatectomy is associated with significant manipulation of the splenoportal venous system. The size of the cylindrical thromboemboli in the allograft portal vein, 6.2xOAxO.2 cm in case 1 and 2.0xO.8xO.8 cm in case 2, seems to correlate with the size of the residual splenic vein in case 1, and the size of the splenic vein remnant proximal to the distal splenic ligature placed for cannulation of the portal cannula through the splenic vein in case 2. Although not confirmatory, it is suggested that the thromboemboli in our donors were formed in the residual splenic vein, and dislodged into the portal vein during liver allograft harvesting.
Although portal vein thrombosis has been rare after liver transplantation in our experience (7), it can occur, and when it does, there is usually no good explanation for a thrombosis that apparently began in the liver allograft and extended doWDward Emboli already present in the graft at the time of organ procurement could be responsible.
When liver allografts are harvested from splenectomized donors, manipulation of the remnant splenic vein or the pancreas should be minimized. and the portal vein of the graft should be examined immediately after allograft hepatectomy in the donor hospital, in order to avoid a disastrous portal vein thrombosis in the recipient.
